Ganaril Tablets (Itopride Hydrochloride)

Adult dose

Adults: Administer 50 mg of itopride hydrochloride orally 3 times a day before meals (take). Reduce the dose as appropriate according to symptoms.

This medication should not be used by patients who have had allergic reactions to this medication or its ingredients. This medication is not administered to patients with gastrointestinal bleeding, obstruction, perforation, or similar problems, as it may stimulate gastrointestinal motility and worsen the situation. This medication contains lactose, so it should be avoided by patients with lactose intolerance or specific genetic metabolic disorders. Rarely, severe allergic reactions such as shock or anaphylaxis symptoms may occur; if symptoms such as low blood pressure, respiratory distress, or skin rashes appear after taking this medication, use should be stopped immediately and medical assistance sought. There may be issues with liver function, so if liver enzyme levels rise or jaundice symptoms occur, the medication should be discontinued and a visit to the hospital is necessary. Gastrointestinal symptoms such as nausea, diarrhea, constipation, abdominal pain, and increased saliva may occur, and neurological symptoms such as headaches, anxiety, sleep disturbances, and dizziness have also been reported. Gynecomastia or hormonal changes may occur; if unusual symptoms appear, consultation with a doctor is advised. Blood tests may show decreased platelet or white blood cell counts, so regular testing is required. Kidney function indicators may rise; thus, careful observation of kidney health is essential. Hypersensitivity reactions such as skin rashes, itching, and tremors may occur, and if symptoms appear, the medication should be stopped immediately. Chest pain or fatigue may rarely occur, so monitoring of bodily condition is important. This medication enhances acetylcholine action, so when taken with other anticholinergics, attention should be given to possible decreased efficacy by adjusting the intervals of dosing. Safety during pregnancy has not been established, so it should only be used when strictly necessary, and during breastfeeding, since this medication may be excreted in breast milk, it should be avoided if possible or breastfeeding should be discontinued. Safety in children has not been sufficiently established; therefore, use should be cautious. Elderly patients may have weakened physical functions, so unusual reactions may occur more easily; symptoms should be closely observed during use, and dose adjustments or discontinuation should be made as necessary. The medication should be kept out of reach of children, not transferred to other containers, and stored carefully to maintain quality and safety.

• Shock
• anaphylactic symptoms
• hypotension
• difficulty breathing
• laryngeal edema
• hives
• pallor
• sweating
• liver dysfunction
• jaundice

This medication is susceptible to air and moisture, so it must be stored in a tightly sealed container. It is essential to maintain a storage temperature between 1 degree and 30 degrees Celsius. Doing so will help safely retain the effectiveness of the medication.

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle - 30 tablets/bottle, 100 tablets/bottle - 100 tablets/bottle, 500 tablets/bottle - 500 tablets/bottle, (for export) 30 tablets (10 tablets/PTP × 3) - 30 tablets/PTP [(for export) 30 tablets (10 tablets/PTP × 3)]